News – Page 466 – Endpoints News

Social media meets science in ‘Lab Shenanigans’ with TikTok-famous researcher — and sometimes Pfizer partner

3 years ago

Biotech-backed nonprofit joins with FDA to standardize process for submitting in vitro pharmacology data

3 years ago

'Really include everyone in the trial': A Q&A with the protocol chair of the PhIII monkeypox antiviral study

3 years ago

Rubius resorts to layoffs and abandons its lead programs as its survival strategy

3 years ago

Two biotechs go for public offerings; Pfizer partner expands oncology collab

3 years ago

With fresh $160M, RayzeBio plots sprint through the clinic for lead radiopharmaceutical program — building on ...

3 years ago

Forge Biologics continues its hot streak with $90M round to boost gene therapy manufacturing services

3 years ago

Implementing 'Right-to-Try': FDA signals likelihood of only minimal manufacturer participation

3 years ago

Acelyrin tops its $250M crossover with new $300M cash raise from blue-chip syndicate

3 years ago

In aftermath of lead drug implosion, ObsEva's restructuring claims 70% of its staffers — reaching into the C-suite

3 years ago

Moonshot refresh: Biden calls to cut cancer death rate by at least 50% in 25 years

3 years ago

Updated: Akero says positive PhIIb data buck the gloomy NASH tide, but questions remain on safety front

3 years ago

Eyeing accelerated approval for Duchenne gene therapy, Sarepta hopes to bring in $1B in bid for profitability

3 years ago

FDA schedules joint advisory committee meeting to consider first over-the-counter birth control pill

3 years ago

Adagio adopts new name, adds Covid cocktail candidate in ‘new day’ bid after initial drug development woes

3 years ago

BioMarin says PhIII gene therapy study participant's cancer is unrelated to therapy

3 years ago

Verily hooks $1B round amid C-suite shuffle

3 years ago

The scientist who pioneered KRAS drugs has a new idea about making them more powerful

3 years ago

On heels of positive data for ATTR drug, Alnylam looks to raise more capital — nearly $1B worth

3 years ago

FDA hires new vaccine director, a year after two senior leaders quit in protest

3 years ago

Nimbus clinches $125M raise via big donor-backed private financing round following Bristol Myers' TYK2 approval

3 years ago

Microsoft sinks deeper into drug AI, inks collab with diabetes giant Novo Nordisk

3 years ago

#ESMO22: Amgen drops the detailed deck for KRAS G12C, with eroding data likely to trigger fresh debate

3 years ago

Relay kicks off public offering, seeking $300M after laying out robust ESMO data

3 years ago

First page Previous page 463 464 465466467 468 469 Next page Last page